/

Companies / Vaxcyte

Vaxcyte

San Carlos, United States

Vaxcyte is dedicated to eliminating bacterial infections such as invasive pneumococcal disease, Group A Strep and Shigella through vaccine innovation

Vaxcyte, based in San Carlos, United States, has 7 investors on file, among them BioRock Ventures, CTI Life Sciences Fund and Foresite Capital. Its site was last checked 13 Nov 2026: site answers.

SEC Form D filings

4 filings

Filed by Vaxcyte, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.

Investors

7 investors on file
InvestorEvidenceType
BioRock VenturesPortfolio pageVenture capital
CTI Life Sciences FundPortfolio pageVenture capital
Foresite CapitalPortfolio pageVenture capital
Frazier Life SciencesPortfolio pageVenture capital
Longitude CapitalPortfolio pageVenture capital
Pivotal Life SciencesPortfolio pageVenture capital
RA CapitalPortfolio pageVenture capital

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Vaxcyte and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when BioRock Ventures adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/vaxcyte.com/investors

# also
GET /v1/companies/vaxcyte.com
GET /v1/companies/vaxcyte.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing